BlackRock Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $3.43M | Buy |
43,233
+7,124
| +20% | +$565K | ﹤0.01% | 1833 |
|
|
2016
Q3 | $2.53M | Buy |
36,109
+3,434
| +11% | +$240K | ﹤0.01% | 1963 |
|
|
2016
Q2 | $1.27M | Buy |
32,675
+3,548
| +12% | +$138K | ﹤0.01% | 2452 |
|
|
2016
Q1 | $1.18M | Buy |
29,127
+299
| +1% | +$12.1K | ﹤0.01% | 2370 |
|
|
2015
Q4 | $2.56M | Buy |
28,828
+12
| +0% | +$1.06K | ﹤0.01% | 1902 |
|
|
2015
Q3 | $2.13M | Sell |
28,816
-464
| -2% | -$34.3K | ﹤0.01% | 2035 |
|
|
2015
Q2 | $2.37M | Buy |
29,280
+28,669
| +4,692% | +$2.32M | ﹤0.01% | 2096 |
|
|
2015
Q1 | $26K | Buy |
611
+10
| +2% | +$426 | ﹤0.01% | 3374 |
|
|
2014
Q4 | $9K | Hold |
601
| – | – | ﹤0.01% | 3709 |
|
|
2014
Q3 | $8K | Hold |
601
| – | – | ﹤0.01% | 3747 |
|
|
2014
Q2 | $9K | Sell |
601
-8,038
| -93% | -$120K | ﹤0.01% | 3662 |
|
|
2014
Q1 | $110K | Buy |
+8,639
| New | +$110K | ﹤0.01% | 3272 |
|